The Committee adopted by consensus a positive opinion for a marketing authorisation Nobivac LoVo L4 (a duplicate of Nobivac L4), from Intervet International B.V., a vaccine for the active immunisation of of dogs against Leptospira interrogans serogroup Canicola serovar Canicola to reduce infection and urinary excretion, L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni to reduce infection and urinary excretion, L. interrogans serogroup Australis serovar Bratislava to reduce infection and L. kirschneri serogroup Grippotyphosa serovar Bananal/Liangguang to reduce infection and urinary excretion.

The Committee adopted by consensus a positive opinion for a marketing authorisation application for Senvelgo (velagliflozin), from Boehringer Ingelheim Vetmedica GmbH, a product intended for the reduction of hyperglycaemia in cats with non-insulin-dependent diabetes mellitus.

The Committee adopted by consensus a positive opinion for a marketing authorisation Bovilis Cryptium,…